COVID-19 vaccine, the world's first DNA shot against the coronavirus, for emergency use in adults and children aged 12 years and above.
The vaccine, developed in partnership with the Department of Biotechnology, is the second home-grown shot to get emergency authorization in the country after Bharat Biotech's Covaxin.
Cadila aims to make 100 million to 120 million doses of ZyCoV-D annually and has begun stockpiling the vaccine. Zydus Group MD Dr Sharvil Patel on Saturday said that by next week, clarity on the price of its recently approved Covid-19 vaccine candidate ZyCOV-D vaccine will come next week.
In a virtual address, Patel also said that supply of vaccines will start in mid-September. “We can scale up production of vaccines to 1